Episodic Therapy for Genital Herpes in Sub-Saharan Africa
Author Information
Author(s): Helen A. Weiss, Gabriela Paz Bailey, Sam Phiri, Gerard Gresenguet, Jerome LeGoff, Jacques Pepin, David A. Lewis, Laurent Belec, Irving F. Hoffman, William C. Miller, Philippe Mayaud
Primary Institution: London School of Hygiene and Tropical Medicine
Hypothesis
Can the variation in impact of acyclovir on ulcer healing in trials across different African countries be explained by differences in the characteristics of the study populations?
Conclusion
Acyclovir may provide a slight benefit in healing genital ulcers, especially in HIV-1 co-infected patients.
Supporting Evidence
- 63% of patients on acyclovir had healed ulcers compared to 57% on placebo.
- 58% of participants were HIV-1 seropositive.
- Small ulcers responded better to acyclovir treatment.
Takeaway
This study looked at how well acyclovir helps heal genital sores in people in Africa, finding it works a bit better for those with HIV.
Methodology
Pooled data from three randomized controlled trials were analyzed to estimate the impact of acyclovir on ulcer healing and lesional HIV-1 RNA.
Potential Biases
Potential biases related to participant selection and adherence to treatment were noted.
Limitations
The study could not evaluate the impact on healing within the first week due to the timing of follow-up visits.
Participant Demographics
The study included 1478 patients, with a median age of 28 years, and a majority were male (63%).
Statistical Information
P-Value
p=0.04
Confidence Interval
95% CI 0.98–1.18
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website